蛋白氨酸酸酶1B是一种调节剂的α-actinin4在质细胞的podocyte
Ming-Fo Hsu1, Yoshihiro Ito1, Jai Prakash Singh2
1Department of Nutrition, University of California Davis, Davis, CA, USA.
Biochimica et biophysica acta. Molecular cell research
|September 20, 2023
概括
研究人员将α-actinin4确定为脏 podocytes 中的蛋白质氨酸酸酶 1B (PTP1B) 的新型基质. 这种相互作用会影响细胞的功能和运动性,这表明损伤的新治疗点.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 淋巴细胞受体对的屏障功能至关重要;受体受体损伤导致蛋白尿和功能障碍.
- 蛋白氨酸酸酶1B (PTP1B) 是一种已知的代谢调节剂,其抑制可以防止受细胞损伤.
- 介导PTP1B在细胞中的作用的特定基质在很大程度上是未知的.
研究的目的:
- 为了在细胞中识别PTP1B的新基质.
- 为了验证α-actinin4作为一个关键的 PTP1B基质参与 podocyte 功能.
主要方法:
- 基质捕捉试验与质谱学相结合,以确定PTP1B基质.
- 在小鼠,人类和细胞培养模型中进行同局部化研究.
- 西方涂抹以评估氨酸酸化水平.
- 胰岛素刺激和瓦纳达特治疗以确认酶基质相互作用.
- 通过siRNA介导的敲击来评估对 podocyte 移动性的功能影响.
主要成果:
- 鉴定出α-actinin4是假定PTP1B基质,并发现它与PTP1B在质细胞和 podocytes 中共定位.
- PTP1B缺乏增加了α-actinin4氨酸酸化,而PTP1B的再表达减少了它.
- α-actinin4直接与PTP1B相互作用,特别是在氨酸残留物486/487处,相互作用由胰岛素和瓦纳达特调节.
- PTP1B和α-actinin4被证明可以调节 podocyte 运动性.
结论:
- 阿尔法-actinin4 是脏 podocytes 中 PTP1B 的新型基质.
- PTP1B-alpha-actinin4相互作用是一个关键的信号节点,影响着 podocyte 功能和运动性.
- 向PTP1B和潜在的α-actinin4可能为治疗细胞损伤提供新的治疗策略.
相关概念视频
Protein Kinases and Phosphatases
13.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
GTPases and their Regulation
8.4K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
8.4K
Glomerular Filtration Rate and its Regulation
2.9K
The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
2.9K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


